Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: A clinico-pathological study

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 6, 2013, Pages 930-938

  Zaidan, Mohamad ^a   Lescure, François Xavier ^a,b   Brochériou, Isabelle ^a,c   Dettwiler, Sarah ^d   Guiard Schmid, Jean Baptiste ^a   Pacanowski, Jérôme ^e   Rondeau, Eric ^a,b,c   Pialoux, Gilles ^a,c   Girard, Pierre Marie ^c,e   Ronco, Pierre ^a,b,c   Plaisie, Emmanuelle ^a,b,c  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FANCONI RENOTUBULAR SYNDROME; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NEPHROTOXICITY; OUTCOME ASSESSMENT; PROTEINURIA; RETROSPECTIVE STUDY; TUBULAR DYSFUNCTION; TUBULOINTERSTITIAL NEPHROPATHY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANTI-HIV AGENTS; BIOPSY; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; KIDNEY TUBULES; MALE; MIDDLE AGED; NEOPLASMS; NEPHRITIS, INTERSTITIAL; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, SEPTIC; YOUNG ADULT;

EID: 84878858436     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10051012     Document Type: Article

References (53)

1. Baker RJ, Pusey CD: The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19: 8-11, 2004
2. Praga M, Gonzalez E: Acute interstitial nephritis. Kidney Int 77: 956-961, 2010
3. Davison AM, Jones CH: Acute interstitial nephritis in the elderly: A report from the UK MRC Glomerulonephritis Register and a review of the literature. Nephrol Dial Transplant 13[Suppl 7]: 12-16, 1998
4. Wyatt CM, Morgello S, Katz-Malamed R, Wei C, Klotman ME, Klotman PE, D'Agati VD: The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 75: 428-434, 2009
5. Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669-673, 1984
6. Gardenswartz MH, Lerner CW, Seligson GR, Zabetakis PM, Rotterdam H, Tapper ML, Michelis MF, Bruno MS: Renal disease in patients with AIDS: A clinicopathologic study. Clin Nephrol 21: 197-204, 1984
7. Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101: 429-434, 1984
8. Rachakonda AK, Kimmel PL: CKD in HIV-infected patients other than HIV-associated nephropathy. Adv Chronic Kidney Dis 17: 83-93, 2010
9. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18: 541-546, 2004
10. Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E:HIV-associated kidney glomerular diseases: Changes with time and HAART. Nephrol Dial Transplant 27: 2349-2355, 2012
11. Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, Atta MG: Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 28: 478-486, 2008
12. Coca S, Perazella MA: Rapid communication: Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity. Am J Med Sci 324: 342-344, 2002
13. Izzedine H, Harris M, Perazella MA: The nephrotoxic effects of HAART. Nat Rev Nephrol 5: 563-573, 2009
14. Atta MG, Deray G, Lucas GM: Antiretroviral nephrotoxicities. Semin Nephrol 28: 563-575, 2008
15. Parkhie SM, Fine DM, Lucas GM, Atta MG: Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis. Clin J Am Soc Nephrol 5: 798-804, 2010
16. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute Dialysis Quality Initiative Workgroup: Acute renal failure- definition, outcome measures, animal models, fluid therapy and information technology needs. Presented at The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-R212, 2004
17. Nochy D, Glotz D, Dosquet P, Pruna A, Guettier C, Weiss L, Hinglais N, Idatte JM, Méry JP, Kazatchkine M, Druet P, Bariety J: Renal disease associatedwith HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 8: 11-19, 1993
18. Peraldi MN, Maslo C, Akposso K, Mougenot B, Rondeau E, Sraer JD: Acute renal failure in the course of HIV infection: A singleinstitution retrospective study of ninety-two patients anad sixty renal biopsies. Nephrol Dial Transplant 14: 1578-1585, 1999
19. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145-1152, 2004
20. Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS: Tenofovir nephrotoxicity: Acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int 78: 1171-1177, 2010
21. Jimenez-Nacher I, Garcia B, Barreiro P, Rodriguez-Novoa S, Morello J,Gonzalez-Lahoz J, de Mendoza C, Soriano V: Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements. J Antimicrob Chemother 62: 816-822, 2008
22. Nelson MR, Katlama C, Montaner JS, Cooper DA, Gazzard B, Clotet B, Lazzarin A, Schewe K, Lange J,Wyatt C, Curtis S, Chen SS, Smith S, Bischofberger N, Rooney JF: The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: The first 4 years. AIDS 21: 1273-1281, 2007
23. Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M: Systematic review and meta-analysis: Renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis 51: 496-505, 2010
24. Izzedine H, Hulot JS, Vittecoq D, Gallant JE, Staszewski S, Launay-Vacher V, Cheng A, Deray G; Study 903 Team: Long-term renal safety of tenofovir disoproxil fumarate in antiretroviralnaive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 20: 743-746, 2005
25. Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM, Ronco P, Rossert J: Fanconi syndrome and renal failure induced by tenofovir: A first case report. Am J Kidney Dis 40: 1331-1333, 2002
26. Rifkin BS, Perazella MA: Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. Am J Med 117: 282-284, 2004
27. Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK, Launay-Vacher V, Deray G: Renal safety of tenofovir in HIV treatment-experienced patients. AIDS 18: 1074-1076, 2004
28. Creput C, Gonzalez-Canali G, Hill G, Piketty C, Kazatchkine M, Nochy D: Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS 17: 935-937, 2003
29. Karras A, Lafaurie M, Furco A, Bourgarit A, Droz D, Sereni D, Legendre C, Martinez F, Molina JM: Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 36: 1070-1073, 2003
30. Perazella MA: Tenofovir-induced kidney disease: An acquired renal tubular mitochondriopathy. Kidney Int 78: 1060-1063, 2010
31. Hall AM,Hendry BM, Nitsch D, Connolly JO: Tenofovir-associated kidney toxicity in HIV-infected patients: A review of the evidence. Am J Kidney Dis 57: 773-780, 2011
32. Woodward CL, Hall AM, Williams IG, Madge S, Copas A, Nair D, Edwards SG, Johnson MA, Connolly JO: Tenofovir-associated renal and bone toxicity. HIV Med 10: 482-487, 2009
33. Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G: Tenofovir-associated acute and chronic kidney disease: A case of multiple drug interactions. Clin Infect Dis 42: 283-290, 2006
34. Said SM, Nasr SH, Samsa R, Markowitz GS, D'Agati VD: Nephrotoxicity of antiretroviral therapy in an HIV-infected patient. Kidney Int 71: 1071-1075, 2007
35. Beaufils H, Deray G, Katlama C,Dohin E,Henin D, Sazdovitch V, Jouanneau C: Foscarnet and crystals in glomerular capillary lumens. Lancet 336: 755, 1990
36. Maurice-Estepa L, Daudon M, Katlama C, Jouanneau C, Sazdovitch V, Lacour B, Beaufils H: Identification of crystals in kidneys of AIDS patients treated with foscarnet. Am J Kidney Dis 32: 392-400, 1998
37. Daudon M, Estepa L, Viard JP, Joly D, Jungers P: Urinary stones in HIV-1-positive patients treatedwith indinavir. Lancet 349: 1294-1295, 1997
38. Brewster UC, Perazella MA: Acute interstitial nephritis associated with atazanavir, a new protease inhibitor. Am J Kidney Dis 44: e81-e84, 2004
39. Izzedine H, M'rad MB, Bardier A, Daudon M, Salmon D: Atazanavir crystal nephropathy. AIDS 21: 2357-2358, 2007
40. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW: Immune reconstitution inflammatory syndrome: Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81: 213-227, 2002
41. French MA, Price P, Stone SF: Immune restoration disease after antiretroviral therapy. AIDS 18: 1615-1627, 2004
42. French MA: HIV/AIDS: Immune reconstitution inflammatory syndrome: A reappraisal. Clin Infect Dis 48: 101-107, 2009
43. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M; IeDEA Southern and Central Africa: Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-analysis. Lancet Infect Dis 10: 251-261, 2010
44. Solal-Celigny P, Couderc LJ, Herman D, Herve P, Schaffar-Deshayes L, Brun-Vezinet F, Tricot G, Clauvel JP: Lymphoid interstitial pneumonitis in acquired immunodeficiency syndromerelated complex. Am Rev Respir Dis 131: 956-960, 1985
45. Itescu S, Brancato LJ, Winchester R: A sicca syndrome in HIV infection: Association with HLA-DR5 and CD8 lymphocytosis. Lancet 2: 466-468, 1989
46. Itescu S, Winchester R: Diffuse infiltrative lymphocytosis syndrome: A disorder occurring in human immunodeficiency virus- 1 infection that may present as a sicca syndrome. RheumDis Clin North Am 18: 683-697, 1992
47. Williams FM, Cohen PR, Jumshyd J, Reveille JD: Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheum 41: 863-868, 1998
48. Basu D,Williams FM, Ahn CW, Reveille JD: Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 55: 466-472, 2006
49. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A,Gengiah T, Nair G, Bamber S, Singh A, Khan M Timing of initiation of antiretroviral drugs during tuberculosis therapy N Engl J Med 362: 697-706, 2010
50. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S,Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Abdool Karim Q: Integration of antiretroviral therapy with tuberculosis treatment.NEngl J Med 365: 1492-1501, 2011
51. Wearne N, Swanepoel CR, Boulle A, Duffield MS, Rayner BL: The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol Dial Transplant 27: 4109-4118, 2012
52. Arendse C, Okpechi I, Swanepoel C: Acute dialysis in HIVpositive patients in Cape Town, South Africa. Nephrology (Carlton) 16: 39-44, 2011
53. Swanepoel CR, Wearne N, Duffield MS, Okpechi IG: The evolution of our knowledge of HIV-associated kidney disease in Africa. Am J Kidney Dis 60: 668-678, 2012